(Q54536990)

31 May 2018

title

No strong association between HER-2/neu protein overexpression and gene amplification in high-grade invasive urothelial carcinomas. (English)

1 reference

31 May 2018

1 reference

Vildan Caner

1

1 reference

31 May 2018

Nilay Sen Turk

2

1 reference

31 May 2018

Fusun Duzcan

3

1 reference

31 May 2018

N Lale Satiroglu Tufan

4

1 reference

31 May 2018

E Canan Kelten

5

1 reference

31 May 2018

Sevil Zencir

6

1 reference

31 May 2018

Yavuz Dodurga

7

1 reference

31 May 2018

Huseyin Bagci

8

1 reference

31 May 2018

S Ender Duzcan

9

1 reference

31 May 2018

publication date

16 April 2008

1 reference

31 May 2018

Pathology Oncology Research

published in

1 reference

31 May 2018

volume

14

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

page(s)

261-266

1 reference

31 May 2018

https://scigraph.springernature.com/pub.10.1007/s12253-008-9027-y

exact match

0 references

cites work

Laser-assisted microdissection of membrane-mounted paraffin sections for polymerase chain reaction analysis: identification of cell populations using immunohistochemistry and in situ hybridization.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12253-008-9027-Y

HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients

21 January 2018

1 reference

12 December 2020

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

1 reference

12 December 2020

The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study

1 reference

12 December 2020

HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications

1 reference

12 December 2020

Tissue microarrays for gene amplification surveys in many different tumor types.

1 reference

12 December 2020

C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?

1 reference

12 December 2020

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder

1 reference

12 December 2020

HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma: systematic analysis applying tissue microarray technique

1 reference

12 December 2020

Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?

1 reference

12 December 2020

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

1 reference

12 December 2020

Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors

1 reference

12 December 2020

HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists

1 reference

12 December 2020

Heterogeneity of erbB-2 gene amplification in bladder cancer

1 reference

12 December 2020

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

1 reference

12 December 2020

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy

1 reference

12 December 2020

Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer

1 reference

12 December 2020

The clinical evaluation of HER-2 status: which test to use?

1 reference

12 December 2020

Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters

1 reference

12 December 2020

HER-2 and TOP2A coamplification in urinary bladder cancer

1 reference

12 December 2020

C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer

1 reference

12 December 2020

Genetic alterations in primary bladder cancers and their metastases.

1 reference

12 December 2020

Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer

1 reference

12 December 2020

Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome

1 reference

12 December 2020

10.1007/S12253-008-9027-Y

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018